Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? [7] (multiple letters)
Küçük Resim Yok
Tarih
2003
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
[No abstract available]
Açıklama
Anahtar Kelimeler
angiotensin 1 receptor antagonist, atenolol, captopril, dipeptidyl carboxypeptidase inhibitor, indapamide, losartan, perindopril, thiazide diuretic agent, anamnesis, cell protection, clinical trial, comorbidity, disease association, disease course, drug efficacy, human, kidney disease, kidney function, letter, mortality, priority journal, recurrent disease, risk assessment, stroke, sudden death, treatment outcome, treatment planning, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Cerebrovascular Accident, Clinical Trials, Humans, Indapamide, Kidney Diseases, Perindopril, Ramipril, Receptor, Angiotensin, Type 1, Receptors, Angiotensin
Kaynak
Stroke
WoS Q Değeri
Scopus Q Değeri
Q1
Cilt
34
Sayı
1
